GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Glaukos Corp (FRA:6GJ) » Definitions » PB Ratio

Glaukos (FRA:6GJ) PB Ratio : 5.74 (As of Apr. 08, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Glaukos PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-08), Glaukos's share price is €74.50. Glaukos's Book Value per Share for the quarter that ended in Dec. 2024 was €12.98. Hence, Glaukos's PB Ratio of today is 5.74.

Good Sign:

Glaukos Corp stock PB Ratio (=6.16) is close to 1-year low of 6.16.

The historical rank and industry rank for Glaukos's PB Ratio or its related term are showing as below:

FRA:6GJ' s PB Ratio Range Over the Past 10 Years
Min: 1.65   Med: 7.84   Max: 135.27
Current: 5.92

During the past 12 years, Glaukos's highest PB Ratio was 135.27. The lowest was 1.65. And the median was 7.84.

FRA:6GJ's PB Ratio is ranked worse than
87.47% of 790 companies
in the Medical Devices & Instruments industry
Industry Median: 2.045 vs FRA:6GJ: 5.92

During the past 12 months, Glaukos's average Book Value Per Share Growth Rate was 44.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 2.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -5.90% per year.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Glaukos was 64.80% per year. The lowest was -13.90% per year. And the median was 17.60% per year.

Back to Basics: PB Ratio


Glaukos PB Ratio Historical Data

The historical data trend for Glaukos's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glaukos PB Ratio Chart

Glaukos Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.87 3.65 3.78 8.29 11.02

Glaukos Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.29 10.16 9.58 10.34 11.02

Competitive Comparison of Glaukos's PB Ratio

For the Medical Devices subindustry, Glaukos's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glaukos's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Glaukos's PB Ratio distribution charts can be found below:

* The bar in red indicates where Glaukos's PB Ratio falls into.


;
;

Glaukos PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Glaukos's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=74.50/12.976
=5.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Glaukos  (FRA:6GJ) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Glaukos PB Ratio Related Terms

Thank you for viewing the detailed overview of Glaukos's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Glaukos Business Description

Traded in Other Exchanges
Address
One Glaukos Way, Aliso Viejo, CA, USA, 92656
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Glaukos Headlines

No Headlines